GrowthCap Top 25 Healthcare Investors - William Dai

William Dai named one of GrowthCap's Top 25 Healthcare Investors of 2022

Apexigen to go public via SPAC merger

Huma.AI Series A & Product Update

2022 SVB Report Results

Robert Kamen joins ShangBay Capital as our newest Senior Advisor

Contraline closes $10.7M Series A Financing Round

Tvardi Therapeutics among Fierce Biotech's "Fierce 15" of 2021

Devoro Medical Reaches Acquisition Agreement with Boston Scientific!

Laplace Interventional Announces $7.9 Million Series A for its Transcatheter Tricuspid Valve